These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32759967)

  • 41. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
    Jiang S; Hillyer C; Du L
    Trends Immunol; 2020 May; 41(5):355-359. PubMed ID: 32249063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 and interferon blockade.
    Diamond B; Volpe BT; VanPatten S; Al Abed Y
    Mol Med; 2020 Nov; 26(1):103. PubMed ID: 33167852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of passive immunization in the age of SARS-CoV-2: an update.
    Fischer JC; Zänker K; van Griensven M; Schneider M; Kindgen-Milles D; Knoefel WT; Lichtenberg A; Tamaskovics B; Djiepmo-Njanang FJ; Budach W; Corradini S; Ganswindt U; Häussinger D; Feldt T; Schelzig H; Bojar H; Peiper M; Bölke E; Haussmann J; Matuschek C
    Eur J Med Res; 2020 May; 25(1):16. PubMed ID: 32404189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 47. A NET-thrombosis axis in COVID-19.
    Hidalgo A
    Blood; 2020 Sep; 136(10):1118-1119. PubMed ID: 32882018
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
    Merad M; Martin JC
    Nat Rev Immunol; 2020 Jun; 20(6):355-362. PubMed ID: 32376901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.
    Diamandis P; Prassas I; Diamandis EP
    Clin Chem Lab Med; 2020 Jun; 58(7):1144-1145. PubMed ID: 32386187
    [No Abstract]   [Full Text] [Related]  

  • 50. Atypical lymphocytes in peripheral blood of patients with COVID-19.
    Weinberg SE; Behdad A; Ji P
    Br J Haematol; 2020 Jul; 190(1):36-39. PubMed ID: 32420613
    [No Abstract]   [Full Text] [Related]  

  • 51. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
    Wu M; Ji JJ; Zhong L; Shao ZY; Xie QF; Liu ZY; Wang CL; Su L; Feng YW; Liu ZF; Yao YM
    Int Immunopharmacol; 2020 Nov; 88():106873. PubMed ID: 32795897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).
    Laterre PF; François B; Collienne C; Hantson P; Jeannet R; Remy KE; Hotchkiss RS
    JAMA Netw Open; 2020 Jul; 3(7):e2016485. PubMed ID: 32697322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 and the immune system.
    Paces J; Strizova Z; Smrz D; Cerny J
    Physiol Res; 2020 Jul; 69(3):379-388. PubMed ID: 32469225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What the immune response to the coronavirus says about the prospects for a vaccine.
    Ledford H
    Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 convalescent plasma: phase 2.
    Knudson CM; Jackson JB
    Transfusion; 2020 Jun; 60(6):1332-1333. PubMed ID: 32374890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 59. Perforin and resistance to SARS coronavirus 2.
    Cunningham L; Simmonds P; Kimber I; Basketter DA; McFadden JP
    J Allergy Clin Immunol; 2020 Jul; 146(1):52-53. PubMed ID: 32422144
    [No Abstract]   [Full Text] [Related]  

  • 60. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
    Jewett A
    Crit Rev Immunol; 2020; 40(2):167-171. PubMed ID: 32749094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.